The authors indicate that the effects of curaxins on p53 and NF-κB, as well as their toxicity to cancer cells, result from “chromatin trapping” of the FACT (facilitates chromatin transcription) complex and casein kinase 2 phosphorylation of p53 at serine 392. The gene discussed is TP53; the disease is cancer.